首页> 外文期刊>Bioorganic and Medicinal Chemistry Letters >5-Lipoxygenase-activating protein inhibitors. Part 2: 3-{5-((S)-1-Acetyl-2,3-dihydro-1H-indol-2-ylmethoxy)-3-tert-butylsulfanyl-1-(4-(5 -methoxy-pyrimidin-2-yl)-benzyl)-1H-indol-2-yl}-2,2-dimethyl-propionic acid (AM679)--a potent FLAP inhibitor.
【24h】

5-Lipoxygenase-activating protein inhibitors. Part 2: 3-{5-((S)-1-Acetyl-2,3-dihydro-1H-indol-2-ylmethoxy)-3-tert-butylsulfanyl-1-(4-(5 -methoxy-pyrimidin-2-yl)-benzyl)-1H-indol-2-yl}-2,2-dimethyl-propionic acid (AM679)--a potent FLAP inhibitor.

机译:5-脂氧合酶激活蛋白抑制剂。第2部分:3- {5-((S)-1-乙酰基-2,3-二氢-1H-吲哚-2-基甲氧基)-3-叔丁基硫烷基-1-(4-(5-甲氧基-嘧啶- 2-基)-苄基)-1H-吲哚-2-基} -2,2-二甲基丙酸(AM679)-一种有效的FLAP抑制剂。

获取原文
获取原文并翻译 | 示例
           

摘要

A series of potent 5-lipoxygenase-activating protein (FLAP) inhibitors are herein described. SAR studies focused on the discovery of novel alicyclic moieties appended to an indole core to optimize potency, physical properties and off-target activities. Subsequent SAR on the N-benzyl substituent of the indole led to the discovery of compound 39 (AM679) which showed potent inhibition of leukotrienes in human blood and in a rodent bronchoalvelolar lavage (BAL) challenge model.
机译:本文描述了一系列有效的5-脂氧合酶激活蛋白(FLAP)抑制剂。 SAR研究的重点是发现新的脂环族部分附加到吲哚核上,以优化药效,物理性质和脱靶活性。随后在吲哚的N-苄基取代基上的SAR导致发现化合物39(AM679),该化合物在人血和啮齿类支气管肺泡灌洗(BAL)攻击模型中显示出对白三烯的有效抑制作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号